Last reviewed · How we verify

Ablysinol — Competitive Intelligence Brief

Ablysinol (Ethanol) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: ethanol. Area: Metabolic.

marketed ethanol GABA A receptor alpha-4/beta-2/delta Metabolic Small molecule Live · refreshed every 30 min

Target snapshot

Ablysinol (Ethanol) — Qol Medcl.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ablysinol TARGET Ethanol Qol Medcl marketed ethanol GABA A receptor alpha-4/beta-2/delta 1946-01-01
Ethamolin ETHANOLAMINE OLEATE Qol Medcl marketed ethanolamine oleate 1988-01-01
Phenoxethol phenoxyethanol marketed phenoxyethanol

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (ethanol class)

  1. Qol Medcl · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ablysinol — Competitive Intelligence Brief. https://druglandscape.com/ci/ethanol. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: